BRIEF published on 06/11/2026 at 07:05, 6 days 14 hours ago Biosynex finalizes the sale of its molecular biology business Restructuring Transfer BIOSYNEX Molecular Biology Rapid Diagnosis
BRIEF published on 06/11/2026 at 07:05, 6 days 14 hours ago Biosynex sells its molecular biology business Strategic Growth Transfer BIOSYNEX Molecular Biology Rapid Diagnosis
BRIEF published on 05/25/2026 at 08:05, 23 days 13 hours ago BIOSYNEX is considering the sale of its Molecular Biology business Pharmaceutical Industry Strategy Transfer BIOSYNEX Molecular Biology
BRIEF published on 05/25/2026 at 08:05, 23 days 13 hours ago Biosynex sells its molecular biology business Transfer BIOSYNEX Molecular Biology Conditions Precedent Pharmaceutical Manufacturer
BRIEF published on 04/30/2026 at 18:05, 1 month 17 days ago BIOSYNEX SA: 2025 Annual Report and Outlook for 2026 EBITDA Revenue BIOSYNEX 2025 Results Outlook 2026
BRIEF published on 04/20/2026 at 18:50, 1 month 27 days ago BIOSYNEX postpones the publication of its 2025 annual accounts BIOSYNEX Backup Procedure Postponement Of Publication Health Diagnosis 2025 Annual Accounts
BRIEF published on 04/20/2026 at 18:50, 1 month 27 days ago BIOSYNEX postpones the publication of its 2025 annual accounts Financial Report Development Backup Annual Accounts BIOSYNEX
BRIEF published on 03/24/2026 at 09:02, 2 months 24 days ago BIOSYNEX SA: Extension of the observation period under safeguard Reorganization BIOSYNEX Backup Procedure Adjournment Debt Repayment Plan
BRIEF published on 03/24/2026 at 07:05, 2 months 24 days ago Renewal of the observation period for BIOSYNEX Reorganization Cost Reduction Backup BIOSYNEX Debt Repayment Plan
BRIEF published on 03/17/2026 at 18:10, 3 months ago Nathalie Roos joins the Board of Directors of BIOSYNEX Board Of Directors Governance Business Transformation BIOSYNEX Nathalie Roos
Published on 06/17/2026 at 16:55, 4 hours 45 minutes ago Snipp Interactive Named a Representative Vendor in the Gartner(R) 2026 Market Guide for Loyalty Program Vendors
Published on 06/17/2026 at 16:45, 4 hours 55 minutes ago Nymox's Nymozarfex(TM) Newly Available for Prostate Treatments for Medical Tourists in Collaboration with the Global Alliance of Regenerative Medicine on Roatan Island in the Caribbean
Published on 06/17/2026 at 14:30, 7 hours 10 minutes ago Solitario Advances 2026 Ponderosa Drilling Program
Published on 06/17/2026 at 14:00, 7 hours 40 minutes ago CHAR Tech Reminds Shareholders of June 18 Investor Update Call
Published on 06/17/2026 at 19:10, 2 hours 30 minutes ago Africa Finance Corporation and Leading Italian Institutions Sign Strategic Cooperation Agreements at AFC-Italy Forum to Mobilise Capital and Accelerate Industrial Development Across Africa
Published on 06/17/2026 at 18:36, 3 hours 4 minutes ago BILENDI: Bilendi announces that Euroland Corporate has initiated coverage of its shares
Published on 06/17/2026 at 18:23, 3 hours 17 minutes ago EQS-Adhoc: Ludwig Beck am Rathauseck-Textilhaus Feldmeier AG: Conclusion of a delisting agreement with Bayerische Gewerbebau AG
Published on 06/17/2026 at 18:05, 3 hours 35 minutes ago WACACO LAUNCHES PRESTINA, A PATENTED MANUAL COFFEE BREWER THAT TURNS THE CUP INTO THE PRESS
Published on 06/17/2026 at 08:45, 12 hours 55 minutes ago Air Liquide is awarded its largest-ever contract in Spain to care for 90,000 patients living with respiratory conditions at home
Published on 06/16/2026 at 11:44, 1 day 9 hours ago Guillemot Corporation S.A. | Weekly report share buyback from June 8 to June 12 2026
Published on 06/15/2026 at 23:00, 1 day 22 hours ago BIOPHYTIS ANNOUNCES THE TEMPORARY SUSPENSION OF THE TRADING OF ITS SHARES
Published on 06/15/2026 at 18:57, 2 days 2 hours ago Reporting on share buyback transactions carried out between June 8 and June 11, 2026
